Detalles de la búsqueda
1.
Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer.
J Urol
; : 101097JU0000000000004010, 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758680
2.
Development of a Visually Calculated SUVmean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to 177Lu-PSMA Therapy: Comparison with Quantitative SUVmean and Patient Outcomes.
J Nucl Med
; 65(6): 904-908, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637137
3.
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.
J Nucl Med
; 65(1): 94-99, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050155
4.
Depression Moderates the Relationship between Trait Anxiety, Worry and Attentional Control in Melanoma Survivors.
Healthcare (Basel)
; 11(23)2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38063665
5.
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT).
Ther Adv Med Oncol
; 15: 17588359231156392, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36872949
6.
177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy.
J Nucl Med
; 64(3): 410-415, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215568
Resultados
1 -
6
de 6
1
Próxima >
>>